Smoking Cessation in Rural Hospitals
Centralized Disease Management for Rural Hospitalized Smokers
1 other identifier
interventional
606
1 country
1
Brief Summary
Our long-term goal is to improve smoking cessation treatment for rural smokers. The objective is to assess the effectiveness of a centralized disease management program for hospitalized smokers that coordinates care across treatment settings and links smokers to existing resources. Our central hypothesis is that Centralized Disease Management (CDM) will increase the use of smoking cessation treatments and lead to greater long term smoking cessation than Counseling alone. Demonstrating the effectiveness of a disease management program and identifying the critical components of such a program will provide a basis for improving the utilization of existing smoking cessation resources while enhancing the treatment of rural hospitalized smokers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2010
CompletedFirst Posted
Study publicly available on registry
February 5, 2010
CompletedStudy Start
First participant enrolled
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedResults Posted
Study results publicly available
April 8, 2019
CompletedApril 8, 2019
April 1, 2019
4.9 years
February 4, 2010
March 12, 2019
April 4, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants With 7-day Point Prevalence Abstinence From Cigarettes, Validated
Participant-reported 7-day point prevalence abstinence from cigarettes, validated by salivary cotinine (\< 15ng/ml) or proxy. Participants who did not respond to the survey were considered current smokers.
12 months
Secondary Outcomes (5)
Number of Participants With 7-day Point Prevalence Abstinence at 3 Months, Self-reported
3 months
Number of Participants With 7-day Point Prevalence Abstinence at 6 Months, Self-reported
6 months
Number of Participants With 7-day Point Prevalence Abstinence at 12 Months, Self-reported
12 months
Number of Participants Reporting Utilization of Smoking Cessation Pharmacotherapy During First 6 Months
6 months
Number of Participants Reporting Utilization of Smoking Cessation Pharmacotherapy Between 6 and 12 Months
12 months
Study Arms (2)
Experimental 1
EXPERIMENTALExperimental: 1 Centralized disease management
Experimental 2
EXPERIMENTALExperimental: 2 Counseling alone
Interventions
Centralized Disease Management (CDM) arm will receive smoking cessation counseling with coordination of pharmacotherapy with their insurance coverage and their health care provider
Counseling (C) arm will receive counseling without the care coordination services.
Eligibility Criteria
You may qualify if:
- Hospitalized in a participating rural hospital
- Aged 18 years or older
- Smoke cigarettes on \>25 of the last 30 days
- Have a home address and telephone
- Willing to participate in phone assessments
You may not qualify if:
- Terminal medical condition with life expectancy \<1 year
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Edward Ellerbeck, MD, MPHlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Related Publications (1)
Ellerbeck EF, Cox LS, Hui SA, Keighley J, Hutcheson TD, Fitzgerald SA, Cupertino AP, Greiner KA, Rigotti NA, Miller NH, Rabius V, Richter KP. Impact of Adding Telephone-Based Care Coordination to Standard Telephone-Based Smoking Cessation Counseling Post-hospital Discharge: a Randomized Controlled Trial. J Gen Intern Med. 2019 Dec;34(12):2804-2811. doi: 10.1007/s11606-019-05220-2. Epub 2019 Jul 31.
PMID: 31367875DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sharon Fitzgerald, MPH
- Organization
- University of Kansas Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Edward Ellerbeck, MD, MPH
University of Kansas Medical Center
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor, Chairman Preventive Medicine
Study Record Dates
First Submitted
February 4, 2010
First Posted
February 5, 2010
Study Start
March 1, 2010
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
April 8, 2019
Results First Posted
April 8, 2019
Record last verified: 2019-04